<DOC>
	<DOCNO>NCT00002315</DOCNO>
	<brief_summary>To determine efficacy oral 882C87 compare oral acyclovir treatment localize herpes zoster immunocompromised patient . To assess safety tolerance oral 882C87 immunocompromised patient .</brief_summary>
	<brief_title>A Comparison 882C87 Versus Acyclovir Treatment Herpes Zoster Patients With Weakened Immune Systems</brief_title>
	<detailed_description>Patients randomize receive either 882C87 acyclovir correspond placebo 14 day , two hundred patient two group . They stratify presence absence HIV infection . Patients undergo 6 month follow-up .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion Criteria Patients must : Acute localized herpes zoster rash present less 72 hour , verify clinical diagnosis . Immunocompromised condition primarily result document HIV infection , malignancy , chemotherapy radiation therapy , solid organ bone marrow transplant , chronic immunosuppressive therapy . Life expectancy least 6 month . Ability cooperate requirement study . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Evidence cutaneous visceral dissemination ( 20 discrete lesion outside adjacent dermatome ) . Acute , lifethreatening condition . Significant malabsorption syndrome gastrointestinal dysfunction may severely reduce drug absorption . Intolerance oral medication . Concurrent Medication : Excluded : Tricyclic antidepressant antiepileptic . Topical application zoster lesion would obscure evaluation . Fluorouracil flucytosine . Systemic therapy agent antiherpetic activity ( 2 week prior first dose day 28 study ) . Probenecid drug likely affect elimination study drug ( 2 day prior first dose day 14 study ) . Capsaicin ( Zostrix ) . Warfarin ( Coumadin ) 14 day treatment . Patients follow prior condition exclude : History intolerance , hypersensitivity , severe drug reaction acyclovir . Prior Medication : Excluded : Systemic therapy agent antiherpetic activity ( include interferon ) within past 2 week . Probenecid drug likely affect elimination 882C87 acyclovir within past 48 hour . Drugs likely interact 882C87 ( e.g. , fluorouracil flucytosine ) within past 7 day . Zoster immune globulin zoster immune plasma within previous month . History alcohol drug abuse within previous 6 month current methadone therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1994</verification_date>
	<keyword>Herpes Zoster</keyword>
	<keyword>Acyclovir</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>